Health Care Services(IN00376.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Health Care Services
IN00376.US
News
View More

Invictus Pharmacy expands with strategic acquisition, enhancing its national platform.

Invictus Pharmacy, under the management of Invictus Ventures Inc., recently disclosed a strategic acquisition and integration of further pharmacy operations. This move solidifies their position as a vertically integrated, nationwide licensed pharmacy platform. The announcement was made on January 28, 2026. The specifics of the acquisition, including the number of new pharmacy operations involved and the impact on patient services, were not disclosed in the announcement.

Unusual Whales·
US
GRDN
+1.85%
SG
BQD
0.00%
Unusual Whales·
US
GRDN
+1.85%
SG
BQD
0.00%

Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared To Competitors

Charles River Laboratories International Inc. (CRL) shares fell 1.21% to $216.88 on Wednesday, marking the second consecutive day of losses. The stock is 5.24% below its 52-week high of $228.88. In comparison, competitors Labcorp Holdings Inc. (LH), Alnylam Pharmaceuticals Inc. (ALNY), and Bio-Techne Corp. (TECH) also experienced declines. Trading volume was significantly below the 50-day average.

Dow Jones·
US
VHT
-0.92%
US
BBH
-1.27%
US
IBB
-1.62%
Dow Jones·
US
VHT
-0.92%
US
BBH
-1.27%
US
IBB
-1.62%

Labcorp Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors

Labcorp Holdings Inc. (LH) shares fell 1.14% to $268.04 on Wednesday, ending a two-day winning streak. The stock is currently 8.74% below its 52-week high of $293.72 reached on October 21. In comparison, IQVIA Holdings Inc. dropped 0.53%, Centene Corp. increased by 0.89%, and Teladoc Health Inc. fell 2.88%. The overall market showed mixed results, with the Dow Jones up 0.02% and the S&P 500 down 0.01%.

Dow Jones·
US
BIB
-3.33%
US
FBT
-1.23%
US
SBIO
-2.09%
Dow Jones·
US
BIB
-3.33%
US
FBT
-1.23%
US
SBIO
-2.09%

Humana's Health Scare Sinks Stock To 9-Year Low. Time To Buy?

Humana's stock plummeted 21% to a nine-year low after a disappointing Medicare Advantage payment increase proposal of just 0.09% for 2027, significantly below analyst expectations. This decline affected the entire managed care sector, with competitors like UnitedHealth and CVS also experiencing losses. Humana's heavy reliance on Medicare Advantage raises concerns about its future profitability and growth, especially with upcoming Q4 earnings. While long-term growth prospects remain, the uncertainty surrounding the new rates suggests investors may want to wait for clearer guidance before making any decisions.

Talkmarkets·
US
HUM
-6.69%
US
IXJ
-1.38%
US
UNH
+4.00%
Talkmarkets·
US
HUM
-6.69%
US
IXJ
-1.38%
US
UNH
+4.00%

Cardinal Health Inc. Stock Underperforms Wednesday When Compared To Competitors

Shares of Cardinal Health Inc. (CAH) fell 1.71% to $210.39 on Wednesday, ending a three-day winning streak. This decline occurred during a mixed trading session, with the Dow Jones up 0.02% and the S&P 500 down 0.01%. Cardinal Health's stock closed 2.36% below its 52-week high of $215.48. In comparison, competitors like UnitedHealth Group rose 4.00%, while Amazon.com and CVS Health saw minor declines and gains, respectively. Trading volume was below the 50-day average.

Dow Jones·
US
IXJ
-1.38%
US
UNH
+4.00%
US
UNHG
+7.61%
Dow Jones·
US
IXJ
-1.38%
US
UNH
+4.00%
US
UNHG
+7.61%
Posts
View More

Today is Super Tuesday, coinciding with the earnings season of the S&P, Nasdaq, and Dow Jones, as well as the Federal Reserve meeting.

📈 The S&P 500 continues to surge, approaching 7,000 points, setti............

美股

$Grab(GRAB.US) trading as if Singapore is about to get invaded 😂😂😂😂

in all seriousness, yes it sucks to be stuck in something that isn’t moving and was just up 35% a few months ago, but it also beg...........................

$Oklo(OKLO.US)OKLO has secured orders and a site approved by the U.S. Department of Energy (DOE). The market is currently focused on the approval progress by the U.S. Nuclear Regulatory Commission (NR...

$Hims & Hers Health(HIMS.US) showing why a no green to red stop is a good thing. None here at this time only an observation. I traded this name a lot in 2025. See if it sets up again in time.

Source: ...

© 2026 Longbridge｜Disclaimer